Site search

Clear filter
2898 results for '' found
ASCENDANCE - ASCiminib Evaluation in Newly diagnosed CML with Dasatinib to Augment response in Complex genomic Etiology (ACTRN12623001338651)
ASCENDANCE - ASCiminib Evaluation in Newly diagnosed CML with Dasatinib to Augment response in Complex genomic Etiology (ACTRN12623001338651)
/
Portico NG - Evaluation of the Navitor Transcatheter Aortic Valve in High and Extreme Risk Patients with Symptomatic Severe Aortic Stenosis
Portico NG - Evaluation of the Navitor Transcatheter Aortic Valve in High and Extreme Risk Patients with Symptomatic Severe Aortic Stenosis
/
A Prospective Cohort Study of Bicuspid Case Selection and Valve Sizing using the ABC Bicuspid Sizing Algorithm for Sapien 3 Balloon Expandable Valve
A Prospective Cohort Study of Bicuspid Case Selection and Valve Sizing using the ABC Bicuspid Sizing Algorithm for Sapien 3 Balloon Expandable Valve
/
Creating A Risk assessment biomarker tool to prevent Seasonal and Thunderstorm Asthma – CARISTA Study (NCT07055542)
Creating A Risk assessment biomarker tool to prevent Seasonal and Thunderstorm Asthma – CARISTA Study (NCT07055542)
/
Targeting peripheral airway dysfunction with small particle bronchodilator in asthma
Targeting peripheral airway dysfunction with small particle bronchodilator in asthma
/
Virtual Reality Integrated Social Recovery therapy for Young People with Early Psychosis (ACTRN12624000234516)
Virtual Reality Integrated Social Recovery therapy for Young People with Early Psychosis (ACTRN12624000234516)
/
A Phase 1b Study Evaluating the Safety and Tolerability of CLB-4000 with or without Peg-IFNa-2a in Subjects with Chronic Hepatitis B (ACTRN12625000204448)
A Phase 1b Study Evaluating the Safety and Tolerability of CLB-4000 with or without Peg-IFNa-2a in Subjects with Chronic Hepatitis B (ACTRN12625000204448)
/
A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of [225Ac]Ac-A9-3408 in Subjects with Unresectable or Metastatic Melanoma Expressing MC1R
A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of [225Ac]Ac-A9-3408 in Subjects with Unresectable or Metastatic Melanoma Expressing MC1R
/
Antigen Triggers in Inflammatory Skin-disease (Trial Not Registered)
Antigen Triggers in Inflammatory Skin-disease (Trial Not Registered)
/
STRIKE: Silicosis Treatment with Infliximab – A Key Evaluation (ACTRN12625000499482)
STRIKE: Silicosis Treatment with Infliximab – A Key Evaluation (ACTRN12625000499482)
/
5 6 7 8 9